Goldman initiated coverage on Lantheus Holdings with a new price target

12/18/24 7:37:47 AM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Goldman initiated coverage of Lantheus Holdings with a rating of Buy and set a new price target of $143.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$LNTH

Date	Price Target	Rating	Analyst
12/18/2024	$143.00	Buy	Goldman
9/3/2024	$175.00	Buy	Redburn Atlantic
7/10/2024	$100.00 → $130.00	Mkt Outperform	JMP Securities
12/18/2023		Outperform → Mkt Perform	William Blair
12/4/2023	$100.00	Outperform	TD Cowen
9/29/2023		Outperform	William Blair
3/8/2023	$120.00	Mkt Outperform	JMP Securities
11/30/2022		Outperform	SVB Leerink